This is a news story, published by ScienceDaily, that relates primarily to Nanowell Grids news.
For more biology news, you can click here:
more biology newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
cell immunotherapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest immunotherapy news, cancer cells news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cell therapy applicationsScienceDaily
•81% Informative
A new subset of T cells that may improve the outcome for patients treated with T-cell therapies may improve outcome for lymphoma patients.
The study uses the patented TIMING (Timelapse Imaging Microscopy in Nanowell Grids ) approach which applies visual AI to evaluate cell behavior, movement and ability to kill.
T cell-based immunotherapy has tremendous value to fight cancer.
VR Score
90
Informative language
96
Neutral language
57
Article tone
formal
Language
English
Language complexity
77
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links